Arthrosi Therapeutics
San Diego
About Arthrosi Therapeutics
Arthrosi Therapeutics develops pharmaceutical treatments centered on gout and related conditions through clinical research and drug development programs. The company advances its investigational oral therapy designed to lower uric acid, address gout flares, and reduce hard crystal deposits in joint tissue by progressing it through late-stage clinical studies. Its work includes conducting randomized controlled trials to gather data on the therapeutic effects and safety profile of its lead compound in diverse patient groups. Arthrosi Therapeutics also engages in regulatory and scientific activities to support potential future approvals and collaborations. The organization communicates progress through published trial milestones and industry announcements.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $277.4M
- Funding stage: M&A
- Last round: Series E (Jun 2025)
- Website: arthrosi.com
- Phone: 714-813-0709
Industries & Categories
Biotechnology, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/arthrosi-therapeutics-57426 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.